Karyopharm Therapeutics I...

4.08
0.22 (5.70%)
At close: Apr 07, 2025, 3:59 PM
4.21
3.19%
Pre-market: Apr 08, 2025, 07:44 AM EDT

Karyopharm Therapeutics Revenue Breakdown

Period Ending Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
License and Service Revenue 8.75M 6.41M 4.45M 5.56M 5.61M 8.74M 437K 1.62M 6.53M
License and Service Revenue Growth +36.64% +44.02% -20.06% -0.84% -35.78% +1899.31% -72.99% -75.23% n/a
Health Care, Other Revenue 241K 203K n/a n/a n/a n/a n/a n/a n/a
Health Care, Other Revenue Growth +18.72% n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2020
Canada Revenue 5M
Canada Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 27.19M 27.63M 31.07M 29.55M 30.69M 30.8M 34.48M 35.91M 34.65M 34.65M 37.34M 38.77M 34.56M 35.1M 36.53M 37.65M 33.93M 30.97M 30.84M 30.68M 28.39M 25.27M 24.66M 27.1M 18.77M 12.97M 9.49M 7.62M 6.15M 5.82M 6.63M 6.26M 6.54M 5.9M 5.96M 5.55M 5.26M 4.76M 6.16M 5.4M
Selling, General, and Administrative Revenue Growth -1.60% -11.07% +5.15% -3.71% -0.38% -10.66% -3.97% +3.63% +0.01% -7.21% -3.69% +12.17% -1.54% -3.90% -2.97% +10.97% +9.57% +0.40% +0.54% +8.06% +12.36% +2.45% -9.01% +44.39% +44.77% +36.64% +24.51% +23.86% +5.76% -12.31% +5.92% -4.23% +10.92% -0.99% +7.24% +5.51% +10.54% -22.66% +14.04% n/a
Research and Development Revenue 33.3M 36.13M 38.28M 35.34M 39.3M 35.55M 31.48M 32.34M 30.93M 31.36M 44.31M 42.06M 44M 45.81M 33.98M 37.05M 37.19M 37.04M 42.59M 34M 31.58M 26.27M 26.52M 37.97M 38.89M 36.43M 44.73M 41.32M 34.83M 25.24M 23.12M 24.08M 20.67M 19.89M 24.58M 21.8M 24.06M 25.92M 27.01M 20.75M
Research and Development Revenue Growth -7.84% -5.61% +8.32% -10.09% +10.55% +12.95% -2.67% +4.55% -1.36% -29.23% +5.34% -4.41% -3.94% +34.80% -8.28% -0.36% +0.40% -13.05% +25.29% +7.66% +20.21% -0.93% -30.17% -2.36% +6.76% -18.57% +8.26% +18.63% +38.02% +9.16% -4.00% +16.51% +3.91% -19.07% +12.77% -9.43% -7.17% -4.01% +30.14% n/a